[ASAP] Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor 🔗 Access full article via Journal of the American Chemical SocietyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon